SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Whittier Trust Co.

Whittier Trust Co. lifted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.1% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 320,740 shares of the exchange traded fund’s stock after purchasing an additional 9,713 shares during the period. Whittier Trust Co. owned approximately 0.42% of SPDR S&P Biotech ETF worth $28,885,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in XBI. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of SPDR S&P Biotech ETF by 198.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after acquiring an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd purchased a new position in SPDR S&P Biotech ETF in the third quarter valued at $141,284,000. Proficio Capital Partners LLC grew its stake in SPDR S&P Biotech ETF by 16,156.1% during the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after purchasing an additional 911,686 shares in the last quarter. Raymond James Financial Inc. acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth $55,529,000. Finally, J.Safra Asset Management Corp increased its holdings in SPDR S&P Biotech ETF by 461.6% during the 4th quarter. J.Safra Asset Management Corp now owns 292,502 shares of the exchange traded fund’s stock worth $26,293,000 after purchasing an additional 240,415 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $87.46 on Thursday. The stock has a 50-day simple moving average of $89.75 and a 200-day simple moving average of $94.53. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The stock has a market capitalization of $5.67 billion, a PE ratio of 11.47 and a beta of 0.99.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.